Literature DB >> 23443184

Renal oncocytoma: contrast-enhanced sonographic features.

Ying Wu1, Lianfang Du, Fan Li, Huiping Zhang, Yingyu Cai, Xiao Jia.   

Abstract

OBJECTIVES: The purpose of this study was to illustrate the features of renal oncocytoma on contrast-enhanced sonography.
METHODS: Five cases of surgical pathologically proven renal oncocytoma were retrospectively reviewed and analyzed in this study. The 5 patients studied included 3 men and 2 women with a mean age of 52.3 years (range, 32-66 years). All patients underwent conventional and contrast-enhanced sonographic examinations before surgery. The sonographic features, enhancement pattern, and dynamic perfusion change of the tumors and renal parenchyma in vascular phases were evaluated and compared to computed tomography.
RESULTS: On grayscale sonography, renal oncocytomas appeared as solitary hypoechoic or isoechoic masses originating from the renal cortex measuring 2 to 6 cm with a well-defined margin. Color Doppler flow imaging showed rich blood flow signals in the periphery and striplike blood flow signals within the masses. On contrast-enhanced sonography, the features of these tumors included early enhancement, hyperenhancement, and fast wash-out compared to the adjacent renal cortex. There were irregular nonenhanced areas seen in the center of the masses (n = 3) and nonenhanced thin rims seen in the periphery (n = 5). Macroscopically, the well-marginated tumors were yellowish brown with a tender texture and were located in the renal cortex. Central irregularly shaped fibrous scars were seen in 3 tumors, consistent with nonenhanced areas on contrast-enhanced imaging.
CONCLUSIONS: Contrast-enhanced sonography can provide valuable hemodynamic information on renal oncocytoma, which may help in making a differential diagnosis of this benign renal tumor in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23443184     DOI: 10.7863/jum.2013.32.3.441

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  8 in total

1.  [Retrospective study of diagnosis and treatment of renal oncocytoma].

Authors:  M Qiu; Y W Zhang; Y Y Fei; C Liu; S H Deng; W He; M Lu; J Lu; X F Hou; L L Ma
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-08-18

Review 2.  Imaging features of solid renal masses.

Authors:  Massimo Galia; Domenico Albano; Alberto Bruno; Antonino Agrusa; Giorgio Romano; Giuseppe Di Buono; Francesco Agnello; Giuseppe Salvaggio; Ludovico La Grutta; Massimo Midiri; Roberto Lagalla
Journal:  Br J Radiol       Date:  2017-07-13       Impact factor: 3.039

Review 3.  [Innovative ultrasound-based diagnosis of renal tumors].

Authors:  K F Stock; J Slotta-Huspenina; H Kübler; M Autenrieth
Journal:  Urologe A       Date:  2019-12       Impact factor: 0.639

Review 4.  Contrast-enhanced ultrasound of the kidneys: principles and potential applications.

Authors:  Ankita Aggarwal; Sneha Goswami; Chandan J Das
Journal:  Abdom Radiol (NY)       Date:  2022-02-12

Review 5.  [CEUS-diagnosis of solid renal tumors].

Authors:  K Stock; H Kübler; T Maurer; J Slotta-Huspenina; K Holzapfel
Journal:  Radiologe       Date:  2018-06       Impact factor: 0.635

6.  Diagnostic Performance of Contrast-Enhanced Ultrasound (CEUS) in the Evaluation of Solid Renal Masses.

Authors:  Thomas Geyer; Vincent Schwarze; Constantin Marschner; Moritz L Schnitzer; Matthias F Froelich; Johannes Rübenthaler; Dirk-André Clevert
Journal:  Medicina (Kaunas)       Date:  2020-11-19       Impact factor: 2.430

Review 7.  Renal Oncocytoma: The Diagnostic Challenge to Unmask the Double of Renal Cancer.

Authors:  Francesco Trevisani; Matteo Floris; Roberto Minnei; Alessandra Cinque
Journal:  Int J Mol Sci       Date:  2022-02-26       Impact factor: 5.923

8.  Predictive value of contrast-enhanced ultrasound combined with conventional ultrasound in solid renal parenchymal lesions.

Authors:  Yingyu Cai; Fan Li; Zhaojun Li; Xin Li; Chunxiao Li; Zhen Xia; Lianfang Du; Rong Wu
Journal:  Br J Radiol       Date:  2021-07-28       Impact factor: 3.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.